UCP4 Gene

UCP4 (Uncoupling Protein 4)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">UCP4 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>UCP4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>UCP4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=UCP4" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

UCP4 (Uncoupling Protein 4), also known as SLC25A27 (Solute Carrier Family 25 Member 27), is a mitochondrial carrier protein primarily expressed in the nervous system. It belongs to the mitochondrial carrier family (SLC25) and is classified as an uncoupling protein due to its ability to transport protons across the inner mitochondrial membrane, dissipating the mitochondrial proton gradient and uncoupling oxidative phosphorylation from ATP synthesis.

UCP4 is encoded by the SLC25A27 gene located on chromosome 6p25.3 (NCBI Gene ID: 285102). Unlike other uncoupling proteins (UCP1-3), UCP4 has unique tissue distribution with predominant expression in the brain and nervous system, suggesting specialized functions in neuronal physiology and neuroprotection.[@smit2019]

Gene and Protein Structure

Gene Organization

UCP4 (Uncoupling Protein 4)

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">UCP4 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>UCP4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>UCP4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=UCP4" target="_blank">Search NCBI</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

UCP4 (Uncoupling Protein 4), also known as SLC25A27 (Solute Carrier Family 25 Member 27), is a mitochondrial carrier protein primarily expressed in the nervous system. It belongs to the mitochondrial carrier family (SLC25) and is classified as an uncoupling protein due to its ability to transport protons across the inner mitochondrial membrane, dissipating the mitochondrial proton gradient and uncoupling oxidative phosphorylation from ATP synthesis.

UCP4 is encoded by the SLC25A27 gene located on chromosome 6p25.3 (NCBI Gene ID: 285102). Unlike other uncoupling proteins (UCP1-3), UCP4 has unique tissue distribution with predominant expression in the brain and nervous system, suggesting specialized functions in neuronal physiology and neuroprotection.[@smit2019]

Gene and Protein Structure

Gene Organization

The SLC25A27 gene spans approximately 30 kb and is located on chromosome 6p25.3. The gene consists of 9 exons that encode a protein of 307 amino acids with a molecular weight of approximately 34 kDa.

Protein Architecture

UCP4 adopts the typical mitochondrial carrier protein fold:

Structural Features

• Transport mechanism: Alternating access - substrate binding triggers conformational changes
• Substrate specificity: Predominantly transports protons, may also transport other small molecules
• N-terminal targeting sequence: Mitochondrial targeting peptide (first ~20 amino acids)
• Glycosylation sites: None (mitochondrial protein)
• Post-translational modifications: Phosphorylation sites, oxidative modifications

Normal Biological Function

Mitochondrial Uncoupling

UCP4 functions as a mitochondrial uncoupler:

The degree of uncoupling is regulated by nucleotides (ATP, ADP, GTP) and fatty acids, similar to other uncoupling proteins.

Neuronal Energy Metabolism

UCP4 plays crucial roles in neuronal energy homeostasis:

• ATP/ADP balance: Modulates cellular ATP levels by regulating oxidative phosphorylation efficiency
• Glucose metabolism: Influences glycolysis and oxidative phosphorylation coupling
• Calcium handling: Regulates mitochondrial calcium uptake and sequestration
• Metabolic flexibility: Allows neurons to adapt to varying energy demands

Calcium Homeostasis

UCP4 interacts with mitochondrial calcium handling:

• Modulates mitochondrial calcium uptake through calcium uniporters
• Regulates calcium release from mitochondria
• Protects against calcium overload-induced cell death
• Coordinates mitochondrial and cytosolic calcium signaling

Neuroprotection

UCP4 provides neuroprotection through multiple mechanisms:

Synaptic Function

UCP4 is implicated in synaptic plasticity:

• Regulates energy availability at synapses
• Modulates neurotransmitter release
• Influences long-term potentiation (LTP)
• Participates in dendritic spine function

Expression Pattern

Tissue Distribution

UCP4 has a highly restricted tissue distribution:

• Brain: Highest expression in the nervous system
• Cortex (all layers)
• Hippocampus (CA1-CA3 pyramidal cells, dentate gyrus)
• Cerebellum (Purkinje cells)
• Basal ganglia
• Hypothalamus
• Brainstem
• Spinal cord: Motor neurons
• Peripheral nervous system: Some sensory neurons
• Low expression: Testis, kidney (minor)

Cellular Distribution

• Neurons: High expression in various neuronal subtypes
• Astrocytes: Lower expression
• Oligodendrocytes: Minimal expression
• Microglia: Very low levels

Subcellular Localization

• Mitochondria: Inner mitochondrial membrane
• Synaptic mitochondria: Particularly high in presynaptic terminals

Development and Aging

• Expression pattern: Present in embryonic brain, increases postnatally
• Aging: Some studies suggest decreased expression with age
• Disease: Altered expression in various neurodegenerative conditions

Disease Associations

Alzheimer's Disease

UCP4 is significantly implicated in Alzheimer's disease:

Mitochondrial Dysfunction in AD

Mitochondrial dysfunction is an early hallmark of AD, and UCP4 plays a central role:

• UCP4 expression is reduced in AD brains, particularly in vulnerable regions (hippocampus, cortex)
• This reduction correlates with disease severity
• Lower UCP4 contributes to increased mitochondrial ROS production
• Impairs neuronal energy metabolism

Amyloid-Beta Toxicity

UCP4 interacts with amyloid-beta pathology:

• Amyloid-beta exposure reduces UCP4 expression in neurons
• UCP4 overexpression protects against amyloid-beta-induced cell death
• UCP4 activation reduces amyloid-beta-induced mitochondrial dysfunction
• UCP4 agonists may restore mitochondrial function in AD models

• Reduced ROS generation
• Preserved ATP levels
• Maintained mitochondrial membrane potential
• Inhibited cytochrome c release

Tau Pathology

UCP4 may also interact with tau pathology:

• Mitochondrial dysfunction in tauopathy may involve UCP4 dysregulation
• UCP4 preservation could protect against tau-induced neurodegeneration

Neuroinflammation

UCP4 has anti-inflammatory properties:

• Reduced UCP4 may contribute to neuroinflammation in AD
• UCP4 restoration could dampen microglial activation
• Cross-talk between metabolic dysfunction and inflammation

Therapeutic Potential

UCP4-based therapeutic strategies for AD:

• Small molecule UCP4 activators
• Gene therapy approaches (AAV-UCP4)
• Lifestyle interventions that upregulate UCP4
• Combination with other mitochondrial protectants

Parkinson's Disease

UCP4 is relevant to Parkinson's disease through several mechanisms:

Dopaminergic Neuron Vulnerability

Dopaminergic neurons in the substantia nigra are particularly vulnerable to metabolic stress:

• UCP4 is expressed in dopaminergic neurons
• UCP4 expression is reduced in PD models
• Loss of UCP4 may contribute to dopaminergic neuron vulnerability

Mitochondrial Complex I Deficiency

PD is associated with complex I deficiency:

• UCP4 can modulate complex I activity
• UCP4 may compensate for complex I dysfunction
• UCP4 activation protects against complex I inhibitors (MPTP, rotenone)

Oxidative Stress

PD involves prominent oxidative stress:

• UCP4 reduces ROS production
• UCP4 overexpression protects dopaminergic neurons
• UCP4 deficiency increases vulnerability to oxidative insults

Alpha-Synuclein Pathology

UCP4 may interact with alpha-synuclein:

• Mitochondrial dysfunction in synucleinopathy involves UCP4
• UCP4 may modulate alpha-synuclein toxicity
• Potential for protective interventions

Neuroprotective Effects

UCP4 overexpression and activation have shown:

• Protection against 6-OHDA toxicity
• Protection against MPTP toxicity
• Preservation of dopaminergic neurons
• Improved motor function in PD models

Amyotrophic Lateral Sclerosis (ALS)

UCP4 may play roles in ALS:

• Mitochondrial dysfunction is prominent in ALS
• UCP4 expression altered in motor neurons of ALS patients
• UCP4 may protect against motor neuron degeneration
• Therapeutic targeting is under investigation

Stroke and Ischemia

UCP4 has protective effects in cerebral ischemia:

• UCP4 expression changes after ischemic injury
• UCP4 overexpression reduces infarct size
• Protects against post-ischemic neuronal death
• Improves functional recovery

• Reduced ROS during reperfusion
• Preserved ATP during ischemia
• Anti-apoptotic effects

Intellectual and Developmental Disorders

UCP4 is implicated in neurodevelopmental conditions:

• Genetic variants associated with autism spectrum disorder
• UCP4 dysfunction may affect neuronal development
• Cognitive function may be influenced by UCP4

Aging

UCP4 expression changes with aging:

• Age-related decline in brain UCP4 expression
• Contributes to age-related mitochondrial dysfunction
• Associated with cognitive decline

Eye Diseases

UCP4 is expressed in retinal neurons:

• Protects retinal ganglion cells
• Implications for glaucoma and retinal degeneration
• Potential for retinal disease therapeutics

Mechanism of Action

Proton Transport and Uncoupling

UCP4 catalyzes proton leak across the inner mitochondrial membrane:

This uncouples substrate oxidation from ATP synthesis, reducing ROS production at high membrane potentials.

UCP4 Neuroprotection Pathway

ROS Regulation

UCP4 reduces ROS through:

• Lowering mitochondrial membrane potential
• Reducing electron leak from electron transport chain
• Decreasing superoxide production at complexes I and III
• Enhancing antioxidant defenses

Calcium Modulation

UCP4 affects mitochondrial calcium:

• Regulates mitochondrial calcium uptake
• Protects against calcium overload
• Modulates calcium-triggered apoptosis

Apoptosis Regulation

UCP4 inhibits apoptosis through:

• Maintaining mitochondrial membrane potential
• Preventing cytochrome c release
• Inhibiting caspase activation
• Preserving mitochondrial integrity

Metabolic Effects

UCP4 influences metabolism:

• Modulates ATP/ADP ratio
• Affects glycolytic flux
• Regulates oxygen consumption
• Influences metabolic flexibility

Therapeutic Implications

UCP4 Activators

Several strategies to activate UCP4:

• Small molecules: Genistein, resveratrol (modest UCP4 activation)
• Physiological activators: Fatty acids, thyroid hormone
• Novel compounds: Under development

Gene Therapy

Viral vector-mediated UCP4 expression:

• AAV vectors for CNS delivery
• Neuron-specific promoters
• Under investigation for AD and PD

Combination Approaches

UCP4-targeted therapies may combine with:

• Mitochondrial antioxidants (CoQ10, MitoQ)
• Metabolic modulators
• Other neuroprotective agents

Challenges

• Specificity of activators for UCP4 vs other UCPs
• Brain penetration of small molecules
• Balancing uncoupling vs ATP production
• Delivery to specific neuronal populations

Interactions with Other Proteins

Mitochondrial Carriers

UCP4 interacts with other SLC25 family members:

• ADP/ATP translocase (ANT)
• Phosphate carrier
• Citrate carrier

Metabolic Enzymes

• Pyruvate dehydrogenase
• Respiratory chain complexes
• ATP synthase

Signaling Proteins

• Protein kinases (PKA, PKC)
• Transcription factors (PGC-1α)

Post-Translational Modifications

Phosphorylation

UCP4 activity is regulated by phosphorylation:

• Serine phosphorylation: Multiple serine residues can be phosphorylated
• Kinase regulation: PKA, PKC, and AMPK can modify UCP4
• Functional consequences: Phosphorylation affects transport activity

Oxidative Modifications

UCP4 is sensitive to oxidative modifications:

• Cysteine oxidation can modulate activity
• Redox regulation links to cellular oxidative stress
• Adaptive responses to ROS

Acetylation

• SIRT1-mediated deacetylation may regulate UCP4
• Links mitochondrial function to cellular metabolism

Genetic and Epigenetic Regulation

Gene Expression Control

UCP4 expression is regulated at multiple levels:

• Transcriptional regulation: PGC-1α coactivation
• Promoter elements: Response to metabolic signals
• mRNA stability: Regulatory elements in 3' UTR

Epigenetic Modifications

• DNA methylation at promoter region
• Histone modifications affecting expression
• Age-related epigenetic changes

Genetic Variants

• Polymorphisms associated with disease susceptibility
• Functional variants affecting protein function
• Population genetics and evolutionary conservation

Neurodegeneration Mechanisms

Mitochondrial Permeability Transition

UCP4 modulates the mitochondrial permeability transition pore:

• Prevents pore opening under stress conditions
• Protects against necrosis and apoptosis
• Maintains mitochondrial integrity

Protein Quality Control

UCP4 interacts with mitochondrial quality control:

• Mitophagy regulation
• Mitochondrial protein turnover
• Stress response pathways

Metabolic reprogramming

UCP4 affects cellular metabolism:

• Shifts toward glycolysis under stress
• Preserves neuronal survival
• Metabolic adaptation in disease

Structural Biology

Protein Topology

UCP4 shares the mitochondrial carrier fold with other SLC25 family members:

• Six transmembrane helices (TMH1-6)
• Three internal tandem repeats
• Carrier-specific substrate binding site
• Matrix and intermembrane space loops

Transport Mechanism

The alternating access model describes transport:

• Matrix-state (inward-facing)
• Intermediate (occluded)
• Cytosol-state (outward-facing)
• Transport cycle completion

Species Conservation

UCP4 is evolutionarily conserved:

• Mammalian orthologs highly similar
• Zebrafish and Drosophila orthologs
• Conservation of key functional residues
• Species-specific regulatory features

Research Methods

Experimental Approaches

• Protein biochemistry: Purification and characterization
• Mitochondrial assays: Respiration and membrane potential
• Live cell imaging: Mitochondrial dynamics
• Genomic approaches: Gene expression profiling

Animal Models

• Knockout mice: UCP4 deletion phenotypes
• Transgenic models: Overexpression studies
• Conditional knockouts: Tissue-specific deletion

Human Studies

• Post-mortem brain analysis
• Genetic association studies
• Biomarker development

Clinical Implications

Biomarker Potential

UCP4 as a biomarker:

• Peripheral blood cell expression
• CSF mitochondrial markers
• Imaging of mitochondrial function

Clinical Trials

• UCP4-targeted compounds in development
• Mitochondrial protectants in AD and PD trials
• Combination therapy approaches

Patient Stratification

• UCP4 expression as disease subtype marker
• Therapeutic response prediction
• Personalized medicine approaches

Summary

UCP4 (SLC25A27) is a brain-specific mitochondrial uncoupling protein that plays critical roles in neuronal energy homeostasis, oxidative stress regulation, and neuroprotection. Its unique expression pattern and functional properties make it a promising therapeutic target for neurodegenerative diseases. In Alzheimer's disease, UCP4 dysfunction contributes to mitochondrial dysfunction, increased ROS production, and neuronal death. In Parkinson's disease, UCP4 protects dopaminergic neurons against oxidative stress and mitochondrial Complex I deficiency. Therapeutic strategies targeting UCP4, including small molecule activators and gene therapy, hold promise for treating these devastating disorders.

See Also

• [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Oxidative stress](/mechanisms/oxidative-stress)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Mitochondrial uncoupling](/mechanisms/mitochondrial-uncoupling)
• [Energy metabolism](/mechanisms/energy-metabolism)

References

Cross-Links

• [Mitochondrial dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Alzheimer's disease](/diseases/alzheimers-disease)
• [Parkinson's disease](/diseases/parkins- [Neuroinflammation](/mechanisms/neuroinflammation)e stress
• [Neuroinflammation](/mechanisms/neuroinflammation) Mitochondrial uncoupling
• Energy metabolism